Filing Details

Accession Number:
0001246360-15-001827
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-21 16:35:08
Reporting Period:
2015-04-17
Filing Date:
2015-04-21
Accepted Time:
2015-04-21 16:35:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1333170 Nxstage Medical Inc. NXTM Electromedical & Electrotherapeutic Apparatus (3845) 043454702
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1341411 H Jeffrey Burbank 350 Merrimack Street
Lawrence MA 01843
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-04-17 10,000 $2.11 886,756 No 4 M Direct
Common Stock Disposition 2015-04-17 10,000 $18.08 876,756 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-04-17 10,000 $0.00 10,000 $2.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
149,274 2009-04-05 2016-03-04 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2014.
  2. This represents the weighted average price for shares sold in multiple transactions at prices ranging from $17.91 to $18.21, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request.